Abraxis Stock Today

Abraxis BioScience cannot be verified against its exchange. It appears that Abraxis BioScience is not available for investing at the moment. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

Abraxis BioScience Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. Abraxis BioScience's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Abraxis BioScience or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Abraxis BioScience is not currently marked as verified by its exchange. Report It!
Abraxis BioScience Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
Abraxis BioScience SEC Filings
Abraxis BioScience SEC Filings Security & Exchange Commission EDGAR Reports
Legal NameAbraxis BioScience
Piotroski F Score
Piotroski F-Score is a popular financial indicator that puts together nine criteria to evaluate the financial strength of Abraxis BioScience based on its profitability, leverage, liquidity, source of funds, and operating efficiency. It is an academic score (developed by Joseph Piotroski in 2002) to determine the current strength of Abraxis BioScience financial position. Scores of 8 and 9 are usually classified as strong value stocks, whereas scores of 2 or below are considered weak value stocks.
 5 - HealthyDetails
Current ValueLast YearChange From Last Year 10 Year Trend
Weighted Average Shares35.9 M36.1 M
Slightly Down
Decreasing
Slightly volatile
Net Cash Flow from Operations5.6 M5.2 M
Significantly Up
Increasing
Slightly volatile
Total AssetsB961.5 M
Sufficiently Up
Increasing
Stable
Total Liabilities323 M255.4 M
Significantly Up
Increasing
Stable
Current Assets402.7 M334.2 M
Fairly Up
Increasing
Slightly volatile
Current Liabilities174.6 M160.7 M
Significantly Up
Increasing
Slightly volatile
Gross Margin0.750.74
Fairly Up
Decreasing
Slightly volatile
Asset Turnover0.270.29
Significantly Down
Decreasing
Slightly volatile
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Abraxis BioScience's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Not RatedUndervalued
Abraxis BioScience (ABII) is traded on NASDAQ Exchange in USA. It is located in null . Abraxis BioScience is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with current market capitalization of 1.63 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Abraxis BioScience's market, we take the total number of its shares issued and multiply it by Abraxis BioScience's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Abraxis BioScience conducts business under Healthcare sector and is part of Pharmaceutical Products industry. The entity has 40.11 M outstanding shares. Abraxis BioScience currently holds about 203.31 M in cash with 4.49 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of -2.244.
Check Abraxis BioScience Probability Of Bankruptcy

Abraxis Stock Against Markets

Picking the right benchmark for Abraxis BioScience stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Abraxis BioScience stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Abraxis BioScience is critical whether you are bullish or bearish towards Abraxis BioScience at a given time.
Abraxis BioScience cannot be verified against its exchange. It appears that Abraxis BioScience is not available for investing at the moment. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

Try Other Stock Suggestions

View Currently Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Abraxis BioScience stock to make a market-neutral strategy. Peer analysis of Abraxis BioScience could also be used in its relative valuation, which is a method of valuing Abraxis BioScience by comparing valuation metrics with similar companies.
Check out Trending Equities. Note that the Abraxis BioScience information on this page should be used as a complementary analysis to other Abraxis BioScience's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Other Tools for Abraxis Stock

When running Abraxis BioScience price analysis, check to measure Abraxis BioScience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abraxis BioScience is operating at the current time. Most of Abraxis BioScience's value examination focuses on studying past and present price action to predict the probability of Abraxis BioScience's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Abraxis BioScience's price. Additionally, you may evaluate how the addition of Abraxis BioScience to your portfolios can decrease your overall portfolio volatility.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go